Clinical Trials Directory

Trials / Sponsors / Health Institutes of Turkey

Health Institutes of Turkey

Other Government · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingNexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL), Relapsed/Refractory Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 2 / Phase 32025-09-11
WithdrawnEfficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women
COVID-19, SARS CoV 2 Infection
Phase 22024-01-01
CompletedObservational National Vaccine Study
COVID-19 Infection
—2022-05-18
CompletedEfficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Heal
COVID-19, Sars-CoV-2 Infection
Phase 22022-02-18
CompletedPhase 2b Booster Vaccination (TURKOVAC) Against COVID-19
COVID-19, Sars-CoV-2 Infection
Phase 22022-01-24
CompletedPhase 3 Booster Vaccination Against COVID-19
COVID-19, Sars-CoV-2 Infection
Phase 32021-10-08
WithdrawnEvaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Pop
Covid19
Phase 22021-10-01
CompletedBooster Vaccination Against COVID-19
COVID-19, Sars-CoV-2 Infection
Phase 22021-07-12
CompletedEfficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vacci
Covid19
Phase 32021-06-21
CompletedEfficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19
COVID-19
Phase 22021-02-10
CompletedClinical Trial For Early SARS-CoV-2 (COVID-19) Treatment
Covid19
Phase 32020-11-16
CompletedSafety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC
COVID-19 Vaccine
Phase 12020-11-05
CompletedClinical Trial For SARS-CoV-2 Vaccine (COVID-19)
COVID-19
Phase 32020-09-14